From a therapeutic perspective, development of novel eEF2K inhibitors is actively being pursued towards novel experimental therapies in cancer due to its role in metabolic adaptations in cancer cells for survival under nutrient deprivation, including nervous system malignancies [16, 34, 42]. Here, EEF2K is linked to cancer.